Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.
about
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disordersDrug models of schizophreniaHomozygous Deletion of Glutathione Peroxidase 1 and Aldehyde Dehydrogenase 1a1 Genes Is Not Associated with Schizophrenia-Like Behavior in MiceOpportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses.Crystal structures of the M1 and M4 muscarinic acetylcholine receptorsAntidepressants for cognitive impairment in schizophrenia--a systematic review and meta-analysis.Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditionsM5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's locationLong-term effects of maternal deprivation on cholinergic system in rat brain.Muscarinic acetylcholine receptors: novel opportunities for drug development.Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia.Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M4 Muscarinic Receptor as a Novel Therapeutic Target.Identification of expression quantitative trait loci associated with schizophrenia and affective disorders in normal brain tissueThe Role of Cannabis within an Emerging Perspective on Schizophrenia
P2860
Q26765419-C39F4B01-22FB-4CC2-89D9-68E58ED11EF9Q28084198-DB5D731B-0153-40A7-BD2E-A4451D842599Q28395280-787130CE-FCAA-4D62-B8AB-9CD6C307C8ADQ34399823-CC389BDB-BF85-4F19-B910-DAEA7F1F60DBQ34404258-386AA3BF-D305-4449-9AA7-1E77501B98FDQ34517431-17540471-B4A9-44A4-A90A-82A815A8F70BQ34613107-05BDBD03-0E14-4F97-B3CF-19314B635E95Q36042479-69859A89-3802-4216-8AE8-66AD343A6EB8Q37603769-C3AA423C-A7D4-44D6-8FC2-70AC391BF0EAQ37664402-A7D1CDF2-8DF9-43DB-9A7C-CC3B85C6899EQ38218059-049564DD-5860-48AD-84C6-050F149EABA6Q48001582-FB212503-165E-4173-B39B-87234ABCF843Q52361116-8A45CBA8-95AF-448C-97F5-DED467B61FD9Q57677495-1DF91AE2-093E-46C8-840C-69144EEB9D5BQ58794814-AF90745F-0C61-41F7-A4A6-91A8943C23BF
P2860
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.
@en
type
label
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.
@en
prefLabel
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.
@en
P2093
P2860
P1433
P1476
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling
@en
P2093
Carrie K Jones
Daniel J Foster
P Jeffrey Conn
P2860
P304
P577
2012-12-01T00:00:00Z